| Medicare Wellpoint NGS | Billing and Coding: Speech-Language Pathology (52866) | 2026-07-14 |
| Medicare Wellpoint NGS | Billing and Coding: Treatment of Varicose Veins of the Lower Extremity (52870) | 2026-07-14 |
| Medicare Wellpoint NGS | Billing and Coding: Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web Based (53018) | 2026-07-14 |
| Medicare Wellpoint NGS | Polysomnography and Sleep Studies – Medical Policy Article (53019) | 2026-07-14 |
| Medicare Wellpoint NGS | Process for Determining Self-Administered Drug Exclusions – Medical Policy Article (53020) | 2026-07-14 |
| Medicare Wellpoint NGS | Billing and Coding: Eculizumab, and Biosimilars: EPYSQLI®-eculizumab-aagh, and BKEMV™-eculizumab-aeeb (54548) | 2026-07-14 |
| Medicare Wellpoint NGS | Billing and Coding: Removal of Benign Skin Lesions (54602) | 2026-07-14 |
| Medicare Wellpoint NGS | Billing and Coding: Single Chamber and Dual Chamber Permanent Cardiac Pacemakers (54909) | 2026-07-14 |
| Medicare Wellpoint NGS | Billing and Coding: Frequency of Hemodialysis (55672) | 2026-07-14 |
| Medicare Wellpoint NGS | Billing and Coding: Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF) (56178) | 2026-07-14 |